Post by goyocafe on Aug 3, 2019 20:55:19 GMT -5
So a new partnership is announced with GoodRx. Do you think GoodRx would be kind enough to update the description on Afrezza to make it a bit more appealing:
"Afrezza (insulin) is used to treat diabetes mellitus, including diabetes type 1 and diabetes type 2. This drug is less popular than comparable drugs. There is currently no generic alternative for Afrezza, but less expensive biosimilar versions may be available in the future. It is not covered by most Medicare and insurance plans, but manufacturer and pharmacy coupons can help offset the cost. The lowest GoodRx price for the most common version of Afrezza is around $972.73, 17% off the average retail price of $1,183.73. Compare insulins."
www.goodrx.com/afrezza
Afrezza (insulin) is used to treat diabetes mellitus, including diabetes type 1 and diabetes type 2. Post approval studies reveal less hyperglycemia and hypoglycemia and greater time in range than other meal time insulins. There is currently no generic alternative for Afrezza, but less expensive biosimilar versions may be available in the future. Afrezza is covered by most insurance with the possibility of a prior authorization required by some plans. Manufacturer and pharmacy coupons can help offset the cost and the manufacturer offers services to help with filling prescriptions. The lowest GoodRx price for the most common version of Afrezza is around $972.73, 17% off the average retail price of $1,183.73. Compare insulins.
"Afrezza (insulin) is used to treat diabetes mellitus, including diabetes type 1 and diabetes type 2. It is a fast acting insulin that starts working faster than traditional insulin. It will not work as long as regular insulin. This drug is less popular than comparable drugs. There is currently no generic alternative for Afrezza, but less expensive biosimilar versions may be available in the future. Afrezza is covered by some Medicare and insurance plans, but some pharmacy coupons or cash prices may be lower. The lowest GoodRx price for the most common version of Afrezza is around $972.73, 17% off the average retail price of $1,183.73. Compare insulins."